| 注册
首页|期刊导航|中国医院用药评价与分析|12例静脉滴注甘露聚糖肽致不良反应报告

12例静脉滴注甘露聚糖肽致不良反应报告

司可意 王利杰

中国医院用药评价与分析2017,Vol.17Issue(1):116-118,3.
中国医院用药评价与分析2017,Vol.17Issue(1):116-118,3.DOI:10.14009/j.issn.1672-2124.2017.01.042

12例静脉滴注甘露聚糖肽致不良反应报告

12 Cases of Adverse Drug Reaction Reports Induced by Mannatide in Intravenous Drip

司可意 1王利杰1

作者信息

  • 1. 河南理工大学第一附属医院/焦作市第二人民医院药学部,河南焦作 454001
  • 折叠

摘要

Abstract

OBJECTIVE:To investigate the adverse drug reactions ( ADR) induced by mannatide in intravenous drip, and to probe into the regularity and clinical manifestations of ADR , so as to provide reference for the rational drug use and avoid ADR in clinic .METHODS:Retrospective analysis was conducted on 12 cases of ADR induced by mannatide in intravenous drip collected by the First Affiliated Hospital of Henan Polytechnic University /Jiaozuo the Second People's Hospital(hereinafter referred to as “our hospital”) from Mar.2012 to Jun.2016.RESULTS: ADR mainly occurred within 30 min after mannatide injection , performed as allergic reactions and respiratory system disorders.Sever ADR were performed as allergic shock and asthma .CONCLUSIONS:Mmannatide in intravenous drip can induce severe ADR , which should be paid close attention during application .Effective rescue measures should be given in time when ADR appears .

关键词

甘露聚糖肽/不良反应/过敏/休克/哮喘

Key words

Mannatide/ADR/Allergy/Shock/Asthma

分类

医药卫生

引用本文复制引用

司可意,王利杰..12例静脉滴注甘露聚糖肽致不良反应报告[J].中国医院用药评价与分析,2017,17(1):116-118,3.

中国医院用药评价与分析

OACSTPCD

1672-2124

访问量0
|
下载量0
段落导航相关论文